Generated by GPT-5-mini| Nurses' Health Study II | |
|---|---|
| Name | Nurses' Health Study II |
| Established | 1989 |
| Location | United States |
| Type | Prospective cohort study |
| Participants | Registered female nurses |
| Fields | Epidemiology, public health, women's health |
Nurses' Health Study II The Nurses' Health Study II is a large prospective cohort investigation begun in 1989 tracking reproductive health, chronic disease, and lifestyle among female registered nurses in the United States. Funded and coordinated by academic and governmental institutions, the study has produced influential findings in oncology, cardiology, endocrinology, and epidemiology through repeated questionnaires and ancillary studies. Collaborators and investigators have included investigators affiliated with leading universities and agencies, and findings have influenced guidelines and policy debates.
The study was launched by investigators linked to Harvard University, Brigham and Women's Hospital, Nurses' Health Study investigators, National Institutes of Health, National Cancer Institute, and other institutions interested in women's health and chronic disease. It enrolled a large cohort of nurses to examine associations between lifestyle factors and outcomes such as breast cancer, coronary heart disease, type 2 diabetes mellitus, and reproductive outcomes including endometriosis and menopause. Over the years, collaborations have involved researchers from Johns Hopkins University, Columbia University, University of California, San Francisco, Yale University, and international partners.
The cohort comprises female registered nurses recruited from across the United States, with baseline data collection in 1989 and biennial follow-up questionnaires modeled after prior large-scale cohorts such as the original Nurses' Health Study and other longitudinal investigations like the Framingham Heart Study. Enrollment criteria emphasized professional licensure and age ranges similar to cohorts at Mayo Clinic and other clinical centers. The sampling frame and retention strategies have been compared with cohort methods used at Harvard School of Public Health and informed by epidemiologic standards from the Centers for Disease Control and Prevention and World Health Organization guidance.
Data collection uses repeated self-administered questionnaires, supplemental food frequency questionnaires patterned after tools validated by investigators at Harvard T.H. Chan School of Public Health, and biospecimen collections similar to protocols used by NCI consortia. Measures include anthropometry, detailed dietary intake, physical activity assessed with instruments influenced by work at Karolinska Institutet, reproductive history, medication use including hormonal therapies reviewed in contexts such as the Women's Health Initiative, and genetic analyses comparable to panels used in genome-wide association consortia including groups at Broad Institute and Wellcome Trust Sanger Institute. Ancillary studies have added imaging, biomarker assays, and nested case–control designs comparable to studies from Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute.
Publications from the cohort have addressed risk factors for breast cancer in parity and age-at-first-birth analyses that intersect with literature from American Cancer Society investigators, associations of adiposity with coronary artery disease paralleling findings from Framingham Heart Study researchers, and links between diet and type 2 diabetes mellitus consistent with work from Harvard Medical School teams. Notable papers have examined the impact of oral contraceptives and hormone replacement therapies in contexts similar to debates involving the Women's Health Initiative and U.S. Preventive Services Task Force, reported associations of shift work with cancer risk comparable to occupational studies by International Agency for Research on Cancer, and explored mental health outcomes with methods akin to investigations by National Institute of Mental Health. High-profile collaborators and authors have included faculty associated with Brigham and Women's Hospital, Harvard Medical School, Columbia University Medical Center, and the cohort's output has been cited in reviews by American Heart Association and American Cancer Society panels.
Findings have informed clinical guidelines and public health recommendations from bodies such as the U.S. Preventive Services Task Force, American Heart Association, and American College of Obstetricians and Gynecologists, influencing counseling on diet, physical activity, and reproductive-health decision-making. Evidence from the study has contributed to risk prediction models used in clinical practice similar to tools disseminated by National Comprehensive Cancer Network and has been integrated into policy discussions within agencies like the Centers for Disease Control and Prevention and National Institutes of Health. The cohort's data resources have supported training and methods development at institutions including Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, and international academic centers.
Critiques of the study mirror concerns raised for other cohorts such as Framingham Heart Study and the original Nurses' Health Study: limited generalizability due to an occupationally defined, predominantly female, and largely United States-based sample; potential measurement error from self-reported data compared with objective measures used in studies at Mayo Clinic or Cedars-Sinai Medical Center; and potential residual confounding despite multivariable modeling approaches employed in epidemiology at Harvard T.H. Chan School of Public Health and statistical work done at Stanford University. Debates over causal inference and policy translation echo discussions in literature involving Institute of Medicine panels and methodological critiques advanced by researchers at University of California, Berkeley.
Category:Cohort studies